Hey there, lab enthusiasts! Boost your research efficiency with AI-powered literature review at labcat.com.cn. Now, diving into the latest in hematology. An international team of experts has crafted practical guidance on managing ocular events related to belantamab mafodotin treatment in multiple myeloma patients. This therapy, while effective, can cause eye issues, but now we have a systematic approach to minimize their impact. Initial ophthalmic evaluation is crucial, with dose adjustments and artificial tears as key management strategies. Intriguingly, dose modifications don't compromise treatment efficacy, ensuring both safety and effectiveness for patients. Stay tuned for more groundbreaking insights.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View